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Abstract:  Arnica montana L. is an important plant bioresource, being traditionally used as medicinal plant, for 
which the scientific and economic interest remains at a high level. The aim of our study was to 
evaluate the bioproductivity for Arnicae folium et caulis in terms of biomass and content in biological 
active compounds originating from the wild populations and in vitro experimental cultures – under 
controlled environment. In situ biomass production registered variations, probably due to the 
different environmental features and also to the management strategies for each site. The 
development of in vitro cultures had as purpose the evaluation of the biomass production and 
production of plant material for the phytochemical screening. The Arnicae folium et caulis samples 
harvested from the wild populations have a higher content in phenolic acids than the Arnicae flos 
from the same area, but the total content in sesquiterpen-lactones was significantly lower. In contrast, 
the samples originating from the in vitro cultures had a low content in phenolic compounds and a 
high content in sesquiterpen-lactones, comparable with Arnicae flos. 
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Introduction 
 
In the current context of the development of basic research in the field of life sciences, 
with applicability in the improvement of the quality of the life, the plant species diversity, by the 
bio-resources offered by it, establishes a domain of priority study to identify and to isolate new 
biologically active compounds, including the evaluation of their activity. 
Plant resources in the mountain areas are a valuable source of raw material, since 
pedo-climatic peculiarities give distinct biosynthetic potential with adaptive significance for 
the plants. This is reflected in the quality of plant material, in terms of the content of 
biologically active principles.  
In this context, Arnica montana L. is one of the species of traditionally used 
medicinal plants for which the scientific and economic interest remains at a high level and 
is aimed at conservation and sustainable issues. A. montana is a perennial herbaceous species 
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of the Asteraceae family with traditional medicinal use in Europe, arnica extract being used 
topically for its anti-inflammatory action. 
The phytocomplex specific to A. montana includes sescviterpenic lactones, mainly 
helenalin, dihidrohelenalin and esters, phenolic acids and flavonoids, respectively. The 
phytochemical studies envisaged the characterization of the biological active compounds 
content for A. montana plant material harvested from wild populations and experimental 
cultures [AIELLO & al. 2012; GANZERA & al. 2008; NIKOLOVA & al. 2013; 
SCHMIDT & al. 1998] and the identification of the environmental factors that influence the 
content in biological active substances [ALBERT & al. 2009; SEEMAN & al. 2010; 
SPITALER & al. 2008]. 
Sescviterpen-lactones have an anti-inflammatory effect, through different 
mechanisms of action involved in inflammatory processes [LYSS & al. 1998]. Phenolic 
acids and flavonoids have antioxidant, cytoprotective and anti-inflammatory activity 
[ZHELEVA-DIMITROVA & BALABANOVA, 2012; WOERDENBAG & al. 1994]. 
In addition, for the plant itself, these biological active compounds present adaptive 
significance with defensive role for A. montana plants as a response to biotic and abiotic 
stress, characteristic for the mountain areas. 
The species A. montana can be a therapeutically valuable bio-resource with multiple 
applications. Studies in the last decade have opened new perspectives on the applicability of 
arnica extract and helenaline in the treatment of some types of cancer and autoimmune diseases 
[HUANG & al. 2005; BERGES & al. 2009]. Also, A. montana is used in human and veterinary 
homeopathy, as well as in a wide range of products in the cosmetics industry. 
The over-exploitation of the species A. montana and the environmental changes 
have led to problems of sustainability; the species has special conservation status in most 
areas of distribution in Europe, in Romania being considered rare or vulnerable [OLTEAN 
& al. 1994; NEGREAN, 2001]. 
Romania is one of the main European countries, providing plant material of A. 
montana on the global market. Although the interest in the species A. montana has remained 
high worldwide, the species is still poorly capitalized in Romania, for both economic and 
scientific purposes. Thus, there is a lack of comprehensive studies integrated into the current 
status of the species in natural populations, i.e., strategies for conservation and recovery by 
creating and promoting local products. Most studies in Romania concentrated on the Apuseni 
Mountains, while in the Romanian Eastern Carpathians the species is mentioned only in 
studies of flora [ZAMFIRESCU, 2006; MICHLER, 2007; MARDARI, 2008]. 
Evaluation of the quality and availability of native plant material gives added 
value to marketing strategies, as the scientific basis leads to the reduction of the 
vulnerability on a competitive international market. 
The aim of our study was to evaluate the bioproductivity for Arnicae folium et 
caulis in terms of biomass and content in biological active compounds originating from the 
wild populations from the northern area of the Romanian Eastern Carpathians and in vitro 
experimental cultures – under controlled environment. The results of the in situ and in vitro 
studies may be used in cultivation strategies. Considering that the cultivation of the species 
involve high costs, and the flower heads production lowers after the 4th year, the 
exploitation of the underground parts of the plant may lead to the fulfilment of the 
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investment plan [PLJEVLJAKUSIC & al. 2012]. Thus, based on the phytochemical 
screening, Arnicae folium et caulis can be also promoted as raw material. 
The assessments on Arnicae flos are the object of a parallel study [STEFANACHE 
& al. 2013], being well documented in literature since Arnicae flos is the official drug 
included in the European Pharmacopoeia. Currently, in human and veterinary homeopathy 
it is used only the Arnicae folium et caulis, respectively Arnicae radix. 
 
Materials and methods 
 
Plant material 
Within the study 5 natural populations of A. montana (Ortoaia 1 – O1, Ortoaia 2 – 
O2, Arini 1 – A1, Arini 2 – A2 and Arini 3 – A3) from the northern area of the Romanian 
Eastern Carpathians, Neamt County, Dorna Arini commune, during the vegetation seasons 
2012 and 2013. The plant material which was the object of this study consists of  Arnicae 
folium et caulis samples collected from plants harvested from the 5 natural areals 
mentioned above (in situ), respectively from plant regenerated through the in vitro plant 
tissue culture, before and after the stage of acclimatization to the ex vitro environment (in 
vitro and ex vitro). 
Assessment of the bioproductivity in terms of biomass 
In situ studies 
The plant material samples were harvested during the vegetation seasons 2012 and 
2013, in the second half of June, in the stage of full flowering. The samples were dried at 
room temperature in the shadow, for about 1 week. 
The assessment of the bioproductivity, in terms of biomass, was determined for an 
average sample of 25 plants. For this samples the fresh biomass, dry biomass and the drying 
ratio was determined. The drying ratio was calculated by dividing the fresh biomass to the 
dry biomass.  
In vitro studies – development of the plant tissue culture 
For the development of the plant tissue culture, the explants consisted of sterile 
plantlets, obtained from the achenes harvested from the natural populations Ortoaia 1 and 
Arini 3. The culture media used within this experiment are presented in the Tab. 1. 
Culture initiation. The plantlets were placed on the MS basal media (M1) 
[MURASHIGE & SKOOG, 1962]. For the shoot inducing and growth variant of the MS 
supplement with the phytohormone BAP (6-benzylaminopurine) were used: 0.5 mg/l (M2) 
and 1.0 mg/L BAP (M3). 
Subcultivation. The first subcultivation was performed after 8 weeks from the 
culture initiation, the following subcultivations being performed every 4–6 weeks 
depending on the multiplication and growth rates.  
Rhisogenesis. The new formed shoots were isolated and transferred on MS culture 
medium, without phytohormones (M4 and M5).  
Acclimatization. After the shoots developed a vigorous root system, they were 
transferred in pots with a mixture of soil and perlite (1:1), placed in an environment with 
high and constant humidity.  
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Tab. 1. Culture medium variants used for in the different stages of the in vitro plant tissue culture  
Culture 
stage 
Medium 
variant 
(code) 
Components 
mg/L g/L 
Macroelements Microelements Vitamins BAP Sucrose Agar 
Initiation M1 MS MS MS - 30 8 
Multiplication 
M2 MS MS MS 1.0 30 8 
M3 MS MS MS 0.5 30 8 
Rhisogenesis 
M4 MS MS MS - 25 8 
M5 MS MS MS - 25 7.5 
 
Assessment of the bioproductivity in terms of content in biological active compounds  
Sample preparation 
Sesquiterpen-lactones. The extracts where prepared according to the European 
Pharmacopoeia, using santonin as internal standard. The percentage content of total 
sesquiterpene lactones, expressed as dihydrohelenalin tiglate, was calculated using the 
formula given in the European Pharmacopoeia.  
Phenolic acids and flavonoids. Several extraction methods were tested, an 
optimum recovery of the compounds being obtain when implementing the protocol 
developed by ALBERT & al. (2009).  
Phytochemical analysis 
HPTLC analysis 
The qualitative assessments for the flavonoids and phenolic acids were achieved 
by means of HPTLC. Stationary phase HPTLC 20x10 cm, silica gel 60 F254, plates 
(Merck); mobile phase: anhydrous formic acid, water, ethylacetate (10:10:80, V/V/V); 
development distance: 7 cm; derivatization: NP solution (10 g/L, in ethylacetate) and PEG 
solution (Macrogol 400, 50 g/L, in dichloromethane); vizualization: 366 nm. 
HPLC analysis 
Sesquiterpene-lactones. The extracts were subjected to HPLC analysis (Nucleodur 
100-5 C18 EC, 4 x 125 mm, 5 µm), flow 1 mL/min; injection volume 20 µL; 225 nm 
detection; mobile phase water + 1 mL/L phosphoric acid (A) and methanol (B); gradient 
55-50-40-35-15-55% solvent A for 0-1.55-9.45-15.95-16.95-18.45-20.95 min (Fig. 1). 
Phenolic acids and flavonoids. The extracts were subjected to HPLC analysis 
(Zorbax SBC18, 3 x 150 mm, 5 µm), flow 1 mL/min.; injection volume 10 µL; DAD 
detection; mobile phase acetonitrile (A) and sodium acetate buffer (2 mM), pH = 3.5 (B); 
gradient : 2-14-20-30-25% solvent A for 0-20-40-50-60 min, after which we switched back 
to the initial conditions for 10 min (Fig. 2). 
 
     
Fig. 1&2. Multiplication and growth, experimental variant O1 (A) and A3 (B), 2 weeks after subcultivation, 
respectively 20 days after the transfer in the ex vitro environment 
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Results and discussion 
 
Assessment of the bioproductivity in terms of biomass 
In situ studies 
The in situ assessment of the bioproductivity in terms of biomass highlighted 
inter-populational variability for the same vegetation season, as well as the inter-
populational variability registered during the 2 vegetations seasons (Fig. 1). 
For the dry weight – Arnicae folium et caulis, the highest values were registered 
for Ortoaia 1 population in 2012, and for the Ortoaia 2 population in 2013. Although for the 
vegetation season 2012 Ortoaia 1 population registered the highest values, for the 
vegetation season 2013 it registered the lowest values compared with the other wild 
populations. From the field observations during 5 consecutive years we observed that 
Ortoaia 1 population has been established relatively recent after the deforestation of the 
area. In the first stage (first 2–3 years) the species had optimum developing conditions with 
low competition rate with other oligotrophic plant species and especially shrub species 
(Vaccinium sp.). Having a higher growth rate than the woody species, the A. montana 
population developed more quickly and spread in this area. In the second stage, when the 
woody species developed more and had a substantial covering percentage, the A. montana 
population declined due also to the high competition rate (for space and nutrients). This 
situation was not observed in the meadows that are properly managed by the owners 
(removing the woody plant species and mowing in order to obtain hay). 
The inter-populational variability registered during the 2 vegetations seasons may 
also be explained through the meteorological peculiarities of each season.  
The drying ratio for Arnicae folium et caulis had values of 4.02 to 5.69, varying 
both between the 5 populations in the same vegetation season and within the same 
population during the 2 vegetation season, fact that can be explained by the different water 
content in the plants and different relative air humidity at the time of harvest. The 
assessment of the drying ration is important in order to develop harvest strategies. 
 
In vitro studies – development of the plant tissue culture 
After the transfer of the plantlets on the shoot inducing medium, in the 22nd – 29th day 
new formed shoots were observed. After the first 2 subcultivations the multiplication rate was of 
3 new shoots/explants. By reducing the BAP concentration from 1.0 mg/L (M2) to 0.5 mg/L 
(M3) both the multiplication and elongation were stimulated (Fig. 2). SMURMACZ-
MAGDZIAK & SUGIER (2012) obtained similar results by reducing the BAP concentration. 
After 2–3 subcultivations on M3 we obtained an average multiplication rate of 7–8 new shoots 
per explant, with a maximum of 12–13 new shoots per explant. 
After about 6 to 8 weeks, 95 % of the shoots developed a vigorous root system, 
being transferred for the acclimatization stage in pots in an environment with high and 
constant humidity. After 2 weeks the pots were transferred in a glasshouse, a survival rate 
of 90 % being obtained for both experimental variants (Fig. 3). 
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Fig. 3. Bioproductivity (in terms of biomass) assessment of the Arnicae folium et caulis harvested from 
the 5 studied wild populations during the vegetation seasons (2012 and 2013): dry substance (d.w. – dry 
weight) and drying ratio 
 
Assessment of the bioproductivity in terms of content in biological active compounds 
 
Qualitative assessments 
The qualitative analysis of the phenolic acids and flavonoids contents was 
performed by means of High Performed Thin Layer Chromatography (HPTLC).   
The phytochemical analysis of the A. montana samples harvested from the studied 
natural populations, highlighted the presence of the phenolic acids (isochlorogenic acids, Rf = 
0.70 – 0.85; cynarine, Rf = 0.50 and chlorogenic acid, Rf = 0.63) and of flavonoids (luteolin-
7-O-glicoside, Rf = 0.47; isoquercitrine, Rf = 0.44 and hyperoside, Rf = 0.40) (Fig. 4).  
The analysis differentiated on the type of organs (leaves and stems) performed for 
the plant material harvested in 2013 had as purpose the assessment of the optimum raw 
material type depending on the final use of the plant material. The phenolic acids were present 
both in Arnicae folium and Arnicae caulis, while the flavonoids were present in all Arnicae 
folium samples and only in some Arnicae caulis samples. Thus, the HPTLC fingerprint of 
Arnicae caulis samples showed a narrower phytochemical spectrum than the Arnicae folium. 
In addition, the size and intensity of the spots corresponding to the flavonoids were lower in 
Arnicae caulis samples, which correlate with a lower content of this compounds (Fig. 5). 
For the samples originating from the in vitro culture, harvested both before and after 
the stage of acclimatization to the ex vitro environment (in vitro and ex vitro), the HPTLC 
fingerprint highlighted only the presence of phenolic acids, the phytochemical spectrum being 
narrower when compared with the samples harvested in situ (Fig. 5). 
   
Quantitative assessments 
The quantitative phytochemical analysis, performed by means of High 
Performance Liquid Chromatography (HPLC), envisaged the total content in phenolic acids 
(expressed in caffeic acid equivalents), flavonoids (expressed in rutin equivalents) and 
sesquiterpen-lactones (expressed in dihydrohelenalin tiglate). All values are expressed as % 
dry weight. 
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In the Arnicae folium et caulis samples harvested from the natural populations the 
phenolic acids were found in total amounts of 1.01–3.02%, and the flavonoids in total 
amounts of 0.11–0.77%. For the samples originating from the in vitro culture, the total 
content in phenolic acids was of 0.05–0.23% for the samples harvested before the 
acclimatization stage (in vitro) and of 0.54–0.82% in the samples harvested after the 
acclimatization stage (ex vitro). Thus, it was observed, for the in vitro experimental 
variants, a significantly lower amount of phenolic acids, the flavonoids being under the 
detection limit, confirming the HPTLC analysis (Fig. 7). 
The total content in sesquiterpen-lactones content, for the in situ samples varied 
from 0.08 to 0.33%, being under the lower limit of 0.4% stated by the European 
Pharmacopoeia for Arnicae flos. For the samples originating from the in vitro experimental 
variants the total content in sesquiterpen-lactones was of 1.15–1.29% for the samples 
harvested before the acclimatization stage (in vitro) and of 1.15–1.38% in the samples 
harvested after the acclimatization stage (ex vitro), being above the lower limit stated by the 
European Pharmacopoeia and comparable with the total content in the Arnicae flos samples 
harvested from the same area or presented in literature: 0.40–1.55% d.w. [SEEMAN & al. 
2010; AIELLO & al. 2012]. 
SCHMIDT & al. (1998) obtained, for samples of leaves harvested from a 
convential culture, a total content in sesquiterpen-lactones of about 0.1%, while in the 
samples originating from the in vitro culture the total content was about 1.3%, with 
qualitative traits similar with the ones of the flower heads samples. 
 
 
Fig. 4. HPTLC chromatogram for phenolic acids and flavonoids for samples harvested from the 
populations of Ortoaia and Arini (2012): 1. Caffeic acid + Cynarine + Chlorogenic acid; 2. O1FC – 
Arnicae folium et caulis, O1; 3. O2FC – Arnicae folium et caulis, O2; 4. A1FC – Arnicae folium et caulis, 
A1; 5. A2FC – Arnicae folium et caulis, A 2; 6. A3FC – Arnicae folium et caulis, A3; 7. Isoquercitrine + 
Rutin; 8. Luteolin-7-O-Glucoside + Hyperoside 
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Fig. 5. HPTLC chromatogram, for phenolic acids and flavonoids for samples harvested from the 
populations of Ortoaia and Arini (2013): 1. Caffeic acid + Cynarine + Chlorogenic acid; 2. O1F – Arnicae 
folium, O1; 3. O1C – Arnicae caulis, O1; 4. O2F – Arnicae folium, O2; 5. O2C – Arnicae caulis, O2; 6. 
A1F – Arnicae folium, A1; 7. A1C – Arnicae caulis, A1; 8. A2F – Arnicae folium, pop. A2; 9. A2C – 
Arnicae caulis, A2; 10. A3F – Arnicae folium, A3; 11. A3C – Arnicae folium, A3; 12. Isoquercitrine + 
Rutin; 13. Luteolin-7-O-Glucoside + Hyperoside 
 
 
Fig. 6. HPTLC chromatogram for phenolic acids and flavonoids for samples harvested from in situ and 
from the in vitro plant tissue culture (experimental variants O1 and A3): 1. Caffeic acid + Cynarine + 
Chlorogenic acid; 2. O1FC12 – Arnicae folium et caulis, O1; 3. O1FCIv – Arnicae folium et caulis, in 
vitro plants, O1; 4. O1FCEv – Arnicae folium et caulis, ex vitro plants, O1; 5. A3FC12 – Arnicae folium 
et caulis, A3; 6. A3HIv – Arnicae folium et caulis, in vitro plants, A3; 7. A3FCEv – Arnicae folium et 
caulis, ex vitro plants, A3; 8. Isoquercitrine + Rutin; 9. Luteolin-7-O-Glucoside + Hyperoside 
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Fig. 7. The total content for the main classes of biological active compound: phenolic acids (exp. in 
caffeic ac. equiv), flavonoids (exp. in rutin equiv.) and sesquiterpen-lactones (exp. in 
dihydrohelenalin tiglate), in the samples harvested from the natural populations of Ortoaia and Arini 
in 2012 and 2013 (in situ) and from the in vitro experimental variants (in vitro and ex vitro); * mean 
value for 2012 and 2013. 
 
Conclusions 
 
The in situ biomass production and the content in biological active compounds is 
fluctuant due to the different environmental features and also to the management strategies 
for each site, parameters that can be partially controlled under cultivation conditions.  
The Arnicae folium et caulis samples harvested from the wild populations have a 
higher content in phenolic acids than the Arnicae flos from the same area, but the total 
content in sesquiterpen-lactones was significantly lower. Thus, based on these results and 
on further studies regarding the qualitative featrures, Arnicae folium et caulis can be 
considered as a raw material for extractive fraction enriched in phenolic compounds.  
In contrast, the samples originating from the in vitro cultures had a low content in 
phenolic compounds and a high content in sesquiterpen-lactones, comparable with Arnicae 
flos – above the lower limit stated in the European Pharmacopoeia. Thus, besides the 
applicability of the biotechnological methods in the production of planting material and in 
conservation strategies, these methods can be used in order to produce raw material in a 
controlled environment. 
The origin of the plant material (in situ or in vitro) can be selected depending on 
the final use of the raw material. 
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